Drugplain

Annovera 17.4 mg/1

segesterone acetate and ethinyl estradiol · RING · Mayne Pharma

No Recall History
Plain English

Annovera is a ring containing segesterone acetate and ethinyl estradiol at 17.4 mg/1, taken vaginal. Manufactured by Mayne Pharma.

Key Facts

Brand Name
Annovera
Generic Name
segesterone acetate and ethinyl estradiol
NDC Code (Product)
68308-752
Manufacturer
Mayne Pharma
Strength
17.4 mg/1
Dosage Form
RING
Route
VAGINAL
Marketing Status
Application #
NDA209627
Drug Class
Estrogen [EPC]
Marketing Start
08/16/2024

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

intermenstrual bleeding40 reports
nausea34 reports
off label use34 reports
vaginal haemorrhage33 reports
drug ineffective25 reports
headache21 reports
vaginal discharge17 reports
vomiting17 reports
device expulsion14 reports
pulmonary embolism13 reports

Frequently Asked Questions

What is Annovera used for?

Annovera contains segesterone acetate and ethinyl estradiol. It is a ring taken vaginal. Consult your doctor for specific uses.

Is Annovera a controlled substance?

Annovera is not classified as a controlled substance by the DEA.

What is the generic name for Annovera?

The generic name for Annovera is segesterone acetate and ethinyl estradiol. There are no other listed brand versions of segesterone acetate and ethinyl estradiol.

What is the NDC code for Annovera 17.4 mg/1?

The NDC (National Drug Code) for Annovera 17.4 mg/1 is 68308-752, listed by Mayne Pharma.

Product NDC

68308-752

Package NDC

68308-752-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)